...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Not adding up!
2
Nov 15, 2021 10:37AM
2
Nov 15, 2021 11:40AM

So, why give it away at this price when:

1. You're at the advanced stage of development that you are with ZEN-3694?

It's a licensing deal. What about the deal is --> giving it away?

 

2. You are expecting some jaw-dropping numbers over at Resverlogix with regards to the Covid-19 trial?

Different company.  How is this relevant?

2
Nov 15, 2021 01:17PM
3
Nov 15, 2021 01:46PM
2
Nov 15, 2021 02:05PM
3
Nov 15, 2021 02:21PM
1
Nov 15, 2021 04:05PM
3
Nov 15, 2021 09:09PM
1
Nov 16, 2021 09:53AM
3
Nov 16, 2021 12:02PM
4
Nov 16, 2021 12:18PM
6
Nov 16, 2021 03:37PM
Share
New Message
Please login to post a reply